TG Therapeutics reports positive Phase 1 data for subcutaneous version of BRIUMVI
Filed June 3, 2026 · Period ending June 3, 2026 · ~1 min read
2 material changes detected in this filing.
Create a free account to read the full summary — it takes 30 seconds.
Partner
Trade TGTX commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jun 3, 2026 3:05 PM